HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Improved clinical outcome measures of knee pain and function with concurrent resolution of subchondral Bone Marrow Edema Lesion and joint effusion in an osteoarthritic patient following Pentosan Polysulphate Sodium treatment: a case report.

AbstractBACKGROUND:
At present, there are no registered products for the treatment of subchondral Bone Marrow Edema Lesion (BML) and associated knee pain. Patients who do not respond to current anti-inflammatory therapies are left with limited treatment options, and may resort to operative management with Total Knee Arthroplasty (TKA). We report the use of Pentosan Polysulphate Sodium (PPS) for the treatment of BMLs of the knee.
CASE PRESENTATION:
We report the case of a 70-year-old female with knee osteoarthritis presenting with a high level of knee pain, scoring 8 on the Numerical Rating Scale (NRS), and functional limitation demonstrating a poor Lysholm Knee Score of 37. MRI scans of the knee revealed subchondral BML in the medial femoral condyle and medial tibial plateau. The patient was administered a course of Pentosan Polysulphate Sodium (PPS) intramuscularly twice weekly, for 3 weeks. MRI scans 2 weeks post-treatment showed complete resolution of the bone marrow edema at the medial femoral condyle and medial tibial plateau with concomitant recovery from pain (NRS pain score of 0), and a 43% improvement of the Lysholm Knee Score. In addition, marked reduction in joint effusion was also demonstrated in the MRI scan post PPS therapy.
CONCLUSION:
The MRI interpretations demonstrate improved clinical outcome measures ensuing therapeutic intervention with PPS, and warranting further investigation into the efficacy of PPS in the treatment of BML associated pain and dysfunction in the osteoarthritic population via randomized controlled trial, or equivalent rigorous methodological technique.
AuthorsMatthew J Sampson, Margie Kabbani, Ravi Krishnan, Michael Nganga, Annika Theodoulou, Jeganath Krishnan
JournalBMC musculoskeletal disorders (BMC Musculoskelet Disord) Vol. 18 Issue 1 Pg. 396 (Sep 12 2017) ISSN: 1471-2474 [Electronic] England
PMID28899386 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anticoagulants
  • Pentosan Sulfuric Polyester
Topics
  • Aged
  • Anticoagulants (administration & dosage)
  • Arthralgia (complications, diagnostic imaging, drug therapy)
  • Bone Marrow Diseases (complications, diagnostic imaging, drug therapy)
  • Edema (complications, diagnostic imaging, drug therapy)
  • Female
  • Humans
  • Injections, Intramuscular
  • Knee Joint (diagnostic imaging, drug effects)
  • Osteoarthritis, Knee (complications, diagnostic imaging, drug therapy)
  • Pentosan Sulfuric Polyester (administration & dosage)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: